February 21-22, 2019 | Manchester, UK
Over 350 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions working in the biomarker space across multiple therapeutic areas, such as immuno-oncology, neuroscience and cardiology.
Over 55 presentations, workshops, round-table and panel discussions focused on the key opportunities and challenges in biomarker research, from precision medicine and companion diagnostics through to digital biomarkers and clinical trials.
Quanterix will present a 30-minute talk on Day 2 within the Innovations in Biomarker Research- Assay Development, Imaging, Data Integration Methods & Bioinformatics stream.
Use of SIMOA® Technology to Improve Measurement of Critical Biomarkers, PK and Immunogenicity parameters in Drug Development and Cell/Gene Therapy
Presented by Dan Sikkema, VP - Acclerator and Pharma Services, Quanterix
February 22, 2019